First characterization of its novel conjugation technology for creating stable, well-defined ADCs with linkers that enable payload attachment to native, unmodified antibodies at a universally ...
Such linkers enable the direct modification of native, unmodified, 'off-the-shelf' IgG antibodies at the universally conserved glutamine residue 295 (Q295) with high precision and therapeutic activity ...